Corticotropin release during ECT in man.
D000311:Adrenal Glands / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000097:blood* / Q000378:metabolism; D000328:Adult; D000768:Anesthesia, General; D001463:Barbiturates; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy; D003863:Depression / Q000097:blood / Q000628:therapy*; D004554:Electric Countershock; D004565:Electroconvulsive Therapy; D005260:Female; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D007099:Imipramine / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009022:Morphine Derivatives; D010902:Pituitary Gland / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000150:complications; D013390:Succinylcholine; D013972:Thyrotropin / Q000378:metabolism; D013997:Time Factors; D014268:Trifluoperazine / Q000627:therapeutic use
D001463:Barbiturates; D009022:Morphine Derivatives; D014268:Trifluoperazine; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D008094:Lithium; D013390:Succinylcholine; D007099:Imipramine; D011241:Prednisone; D006854:Hydrocortisone